Breaking News Instant updates and real-time market news.

ZBH

Zimmer Biomet

$101.98

-0.38 (-0.37%)

, SYK

Stryker

$112.95

0.11 (0.10%)

08:52
11/29/16
11/29
08:52
11/29/16
08:52

Citi upgrades Zimmer to Neutral on Tom Price appointment

Citi analyst Amit Hazan upgraded Zimmer Biomet Holdings to Neutral saying the selection of Tom Price to head Health and Human Services "all but ensures current bundled payment programs may be significantly diluted." This removes a major risk to the U.S. reconstruction market, Hazan tells investors in a research note. He raised his price target for Zimmer shares to $108 from $95. The analyst keeps a Sell rating on Stryker (SYK).

ZBH

Zimmer Biomet

$101.98

-0.38 (-0.37%)

SYK

Stryker

$112.95

0.11 (0.10%)

  • 29

    Nov

  • 12

    Dec

ZBH Zimmer Biomet
$101.98

-0.38 (-0.37%)

11/01/16
11/01/16
UPGRADE
Target $148

Strong Buy
Zimmer Biomet upgraded to Strong Buy at Needham
As previously reported, Needham analyst Mike Matson upgraded Zimmer Biomet to Strong Buy from Buy despite the company's missed Q3 revenue, since he views the issues as temporary and expects its revenue growth to return to about 4% during 2017. Nonetheless, he lowered his price target on the shares to $148 from $150.
11/08/16
NRCS
11/08/16
DOWNGRADE
NRCS
Neutral
Zimmer Biomet downgraded to Neutral from Buy at Northcoast
11/22/16
CLVD
11/22/16
NO CHANGE
CLVD
Zimmer Biomet supply issues impacting hip and knee, says Cleveland Research
Cleveland Research analyst Rob Eich said checks indicate Zimmer's hip and knee sales in the US are being impacted by changes/issues in raw material sourcing and expects COGS to be higher near-term. The analyst said issues have been resolved but could take months to rebuild supply. Eich rates Zimmer a Neutral.
11/29/16
SBSH
11/29/16
UPGRADE
SBSH
Neutral
Zimmer Biomet upgraded to Neutral from Sell at Citi
SYK Stryker
$112.95

0.11 (0.10%)

10/14/16
RHCO
10/14/16
INITIATION
RHCO
Buy
Stryker initiated at SunTrust
As noted earlier, SunTrust initiated Stryker with a $140 price target and Buy rating. Analyst Bruce Nudell says that the company's U.S. brands are strong, while it has shown the ability to very effectively manage technology and businesses it has acquired. Nudell expects the company's revenue and profit growth to exceed those of its peers. Target $140.
10/31/16
PIPR
10/31/16
NO CHANGE
PIPR
Overweight
Zimmer Biomet pullback on earnings a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien noted that Zimmer Biomet (ZBH) reported "slightly weak" Q3 results and cut its guidance due to internal supply issues. However, he thinks the company should be able to re-engage customers and move closer to market growth next year after resolving the issues, which he expects it to fix in "probably" the next two quarters. Noting that the post-earnings decline puts Zimmer's value at a 31% discount to peer Stryker (SYK), which is much wider than average, the analyst points to the pullback as a buying opportunity and keeps an Overweight rating on Zimmer shares.
11/01/16
BMOC
11/01/16
UPGRADE
BMOC
Market Perform
Stryker upgraded to Market Perform from Underperform at BMO Capital
11/01/16
BMOC
11/01/16
UPGRADE
BMOC
Market Perform
Stryker upgraded on positive catalysts at BMO Capital
As noted earlier, BMO Capital upgraded Stryker to Market Perform from Underperform. Analyst Joanne Wuensch says that the company's Q3 results were very strong, while the company's upcoming analyst event should alleviate investors' concerns. The analyst had previously expected the company to be hurt by the increased use of bundled payments, but she says that this has not materialized. Target $125.

TODAY'S FREE FLY STORIES

STBA

S&T Bancorp

$40.99

-0.02 (-0.05%)

12:57
10/17/17
10/17
12:57
10/17/17
12:57
Hot Stocks
S&T Bancorp raises dividend 10% to 22c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 15

    Nov

IPXL

Impax

$19.95

-0.85 (-4.09%)

12:54
10/17/17
10/17
12:54
10/17/17
12:54
Recommendations
Impax analyst commentary  »

Impax merger makes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GM

General Motors

$45.42

-0.34 (-0.74%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Hot Stocks
NY Governor says GM applying to test autonomous vehicles in state in early 2018 »

New York Governor Andrew…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

IPXL

Impax

$19.95

-0.85 (-4.09%)

12:51
10/17/17
10/17
12:51
10/17/17
12:51
Recommendations
Impax analyst commentary  »

Impax combination with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GOOGL

Alphabet Class A

$1,009.35

1.48 (0.15%)

12:50
10/17/17
10/17
12:50
10/17/17
12:50
Periodicals
Alphabet to unfold site in Toronto, Reuters reports »

Alphabet is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

WLL

Whiting Petroleum

$5.13

-0.135 (-2.57%)

12:45
10/17/17
10/17
12:45
10/17/17
12:45
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

MAR

Marriott

$114.75

-0.36 (-0.31%)

12:39
10/17/17
10/17
12:39
10/17/17
12:39
Hot Stocks
Marriott says Ed Ryan to retire as general counsel »

Marriott International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 30

    Nov

VSTM

Verastem

$4.21

-0.14 (-3.22%)

12:35
10/17/17
10/17
12:35
10/17/17
12:35
Conference/Events
Verastem management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

VALE

Vale

$10.28

-0.225 (-2.14%)

12:34
10/17/17
10/17
12:34
10/17/17
12:34
Periodicals
Vale seeks partner to invest in New Caledonia mine, FT reports »

Vale is seeking a partner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$3.21

-0.03 (-0.93%)

12:33
10/17/17
10/17
12:33
10/17/17
12:33
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

CREE

Cree

$29.28

-0.08 (-0.27%)

12:29
10/17/17
10/17
12:29
10/17/17
12:29
Technical Analysis
Technical Earnings Preview: Cree near top of range ahead of results »

The shares were trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PYPL

PayPal

$67.31

-1.35 (-1.97%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 29

    Nov

LNG

Cheniere Energy

$48.20

0.48 (1.01%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Options
Cheniere Energy call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
10/17/17
10/17
12:25
10/17/17
12:25
General news
U.S. corporate bond update: the calendar is relatively slim »

U.S. corporate bond…

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
Federal Reserve Bank of Philadelphia President speaks at summit »

Federal Reserve Bank of…

12:25
10/17/17
10/17
12:25
10/17/17
12:25
Conference/Events
American Association for Cancer Research holds a webinar »

Webinar entitled,…

GOOG

Alphabet

$992.00

2.32 (0.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Hot Stocks
Google refreshes Google Calendar for web »

Google said in a post to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 29

    Nov

JNJ

Johnson & Johnson

$139.15

3.03 (2.23%)

12:20
10/17/17
10/17
12:20
10/17/17
12:20
Periodicals
Appeals court throws out $72M verdict against J&J, St. Louis Post-Dispatch says »

The appeals court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

12:20
10/17/17
10/17
12:20
10/17/17
12:20
General news
Treasury's $40 B 4-week bill garnered solid results »

Treasury's $40 B…

SPX

S&P 500

12:19
10/17/17
10/17
12:19
10/17/17
12:19
Hot Stocks
Trump expected to pick Fed chair before Asia trip, CNBC reports »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
10/17/17
10/17
12:17
10/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
10/17/17
10/17
12:16
10/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$16.21

0.135 (0.84%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Periodicals
Snap says advertising will stay main source of revenue, Bloomberg says »

Snap's head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 07

    Nov

HBI

Hanesbrands

$23.28

-0.11 (-0.47%)

12:15
10/17/17
10/17
12:15
10/17/17
12:15
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.